102 related articles for article (PubMed ID: 9634113)
1. Dynamic magnetic resonance imaging in evaluating suspicious breast lesions: correlation with pathologic findings.
Snow RD; Dyess DL; Harpen MD; Kreisberg CN; Tucker JA
South Med J; 1998 Jun; 91(6):527-32. PubMed ID: 9634113
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic analysis of Gd-DTPA enhancement in dynamic three-dimensional MRI of breast lesions.
den Boer JA; Hoenderop RK; Smink J; Dornseiffen G; Koch PW; Mulder JH; Slump CH; Volker ED; de Vos RA
J Magn Reson Imaging; 1997; 7(4):702-15. PubMed ID: 9243392
[TBL] [Abstract][Full Text] [Related]
3. Dynamic MRI of the breast.
Ercolani P; Valeri G; Amici F
Eur J Radiol; 1998 May; 27 Suppl 2():S265-71. PubMed ID: 9652533
[TBL] [Abstract][Full Text] [Related]
4. MRI-detected suspicious breast lesions: predictive values of kinetic features measured by computer-aided evaluation.
Wang LC; DeMartini WB; Partridge SC; Peacock S; Lehman CD
AJR Am J Roentgenol; 2009 Sep; 193(3):826-31. PubMed ID: 19696298
[TBL] [Abstract][Full Text] [Related]
5. Magnetic Resonance Female Breast Imaging (MRFBI) - Evaluation of the Changes in Signal Intensity over Time Pre- and Post-administration of 0.2 mmol/kg Gd-DTPA.
Schedel H; Oellinger H; Kohlschein P; Siewert C; Hadijuana J; Blohmer JU; Kissner T; Felix R
Zentralbl Gynakol; 2002 Feb; 124(2):104-10. PubMed ID: 11935495
[TBL] [Abstract][Full Text] [Related]
6. Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study.
Jacobs MA; Barker PB; Argani P; Ouwerkerk R; Bhujwalla ZM; Bluemke DA
J Magn Reson Imaging; 2005 Jan; 21(1):23-8. PubMed ID: 15611934
[TBL] [Abstract][Full Text] [Related]
7. [Combination of low and high resolution T1-weighted sequences for improved evaluation of morphologic criteria in dynamic contrast enhanced MRI of the breast].
Vomweg TW; Teifke A; Schreiber WG; Schmidt M; Thelen M
Rofo; 2002 Nov; 174(11):1445-9. PubMed ID: 12424673
[TBL] [Abstract][Full Text] [Related]
8. Dynamic sequential 3D gadolinium-enhanced MRI of the whole breast.
Heiberg EV; Perman WH; Herrmann VM; Janney CG
Magn Reson Imaging; 1996; 14(4):337-48. PubMed ID: 8782170
[TBL] [Abstract][Full Text] [Related]
9. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique.
Boetes C; Barentsz JO; Mus RD; van der Sluis RF; van Erning LJ; Hendriks JH; Holland R; Ruys SH
Radiology; 1994 Dec; 193(3):777-81. PubMed ID: 7972823
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of breast tumors by contrast-enhanced MR imaging: comparison between the diagnostic performance of dynamic enhancement patterns and morphologic features.
Goto M; Ito H; Akazawa K; Kubota T; Kizu O; Yamada K; Nishimura T
J Magn Reson Imaging; 2007 Jan; 25(1):104-12. PubMed ID: 17152054
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time.
Renz DM; Diekmann F; Schmitzberger FF; Pietsch H; Fallenberg EM; Durmus T; Huppertz A; Böttcher J; Bick U; Hamm B; Lawaczeck R
Invest Radiol; 2013 Feb; 48(2):69-78. PubMed ID: 23262793
[TBL] [Abstract][Full Text] [Related]
12. Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI.
Chen W; Giger ML; Bick U; Newstead GM
Med Phys; 2006 Aug; 33(8):2878-87. PubMed ID: 16964864
[TBL] [Abstract][Full Text] [Related]
13. [The MRT of the breast with 2D-spin-echo and gradient-echo sequences in diagnostically problematic cases].
Allgayer B; Lukas P; Loos W; Kersting-Sommerhoff B
Rofo; 1993 May; 158(5):423-7. PubMed ID: 8490150
[TBL] [Abstract][Full Text] [Related]
14. Separation of benign and malignant breast lesions using dynamic contrast enhanced MRI in a biopsy cohort.
Kim SG; Freed M; Leite APK; Zhang J; Seuss C; Moy L
J Magn Reson Imaging; 2017 May; 45(5):1385-1393. PubMed ID: 27766710
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of mammographic breast lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI.
Sommer H; Tiling R; Pechmann M; Kindermann G; Kress K; Moser R; Tatsch K; Hahn K; Pfluger T; Assemi C
Zentralbl Gynakol; 1997; 119(1):6-11. PubMed ID: 9050197
[TBL] [Abstract][Full Text] [Related]
16. Benign and malignant breast lesions: diagnosis with multiparametric MR imaging.
Jacobs MA; Barker PB; Bluemke DA; Maranto C; Arnold C; Herskovits EH; Bhujwalla Z
Radiology; 2003 Oct; 229(1):225-32. PubMed ID: 14519877
[TBL] [Abstract][Full Text] [Related]
17. Comparative utility of MRI perfusion with MSIDR and DWIBS for the characterization of breast tumors.
Zhang B; Zhu B; Li M; Yuan L; Yuan L; Zhang X; Yu H; Li C; Lu F; Zhou Z; Zhuang X
Acta Radiol; 2012 Jul; 53(6):607-14. PubMed ID: 22761342
[TBL] [Abstract][Full Text] [Related]
18. Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging.
Hecht EM; Israel GM; Krinsky GA; Hahn WY; Kim DC; Belitskaya-Levy I; Lee VS
Radiology; 2004 Aug; 232(2):373-8. PubMed ID: 15215544
[TBL] [Abstract][Full Text] [Related]
19. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution.
Kuhl CK; Schild HH; Morakkabati N
Radiology; 2005 Sep; 236(3):789-800. PubMed ID: 16118161
[TBL] [Abstract][Full Text] [Related]
20. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis.
Buadu LD; Murakami J; Murayama S; Hashiguchi N; Sakai S; Masuda K; Toyoshima S; Kuroki S; Ohno S
Radiology; 1996 Sep; 200(3):639-49. PubMed ID: 8756909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]